Dalbavancin and Oritavancin: An Innovative Approach to the Treatment of Gram‐Positive Infections

E-ISSN： 1875-9114|35|10|935-948

ISSN： 0277-0008

Source： PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol.35, Iss.10, 2015-10, pp. : 935-948

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of daptomycin to treat drug-resistant Gram-positive bone and joint infections

By Finney Michael S. Crank Christopher W. Segreti John

Current Medical Research and Opinion, Vol. 21, Iss. 12, 2005-12 ,pp. : 1923-1926

Informa Healthcare

Access to resources Recommend Favorite

Increasing the usefulness of antibiotics: Treatment of infections caused by gram‐negative bacilli

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 11, Iss. 2, 1970-03 ,pp. : 161-167

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proinflammatory Activity of Cell-wall Constituents from Gram-positive Bacteria

By Moreillon P. Majcherczyk P.A.

Scandinavian Journal of Infectious Diseases, Vol. 35, Iss. 9, 2003-09 ,pp. : 632-641

Informa Healthcare

Access to resources Recommend Favorite

Multiple‐Dose Oritavancin Evaluation in a Retrospective Cohort of Patients with Complicated Infections

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 38, Iss. 1, 2018-01 ,pp. : 152-159

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gram-Negative, but Not Gram-Positive, Bacteria Elicit Strong PGE₂ Production in Human Monocytes

By Hessle Christina C. Andersson Bengt Wold Agnes E.

Inflammation, Vol. 27, Iss. 6, 2003-12 ,pp. : 329-332

Springer Publishing Company

Access to resources Recommend Favorite